To assess whether the castPCRTM can reliably detect AKT1 E17K mutations in gynecological tumors samples as well, an analytical validation was performed using 142 gynecological FFPE tumor-derived DNA samples with unknown AKT1 mutation status. This evidence concerns the gene AKT1 and neoplasm.